Voyager Therapeutics (VYGR) Operating Margin: 2015-2025
Historic Operating Margin for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -228.31%.
- Voyager Therapeutics' Operating Margin fell 17236.00% to -228.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -446.84%, marking a year-over-year decrease of 45239.00%. This contributed to the annual value of -104.11% for FY2024, which is 15291.00% down from last year.
- According to the latest figures from Q3 2025, Voyager Therapeutics' Operating Margin is -228.31%, which was up 67.58% from -704.33% recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Operating Margin ranged from a high of 1,584.71% in Q4 2022 and a low of -3,244.68% during Q1 2022.
- In the last 3 years, Voyager Therapeutics' Operating Margin had a median value of -228.31% in 2025 and averaged -298.43%.
- Its Operating Margin has fluctuated over the past 5 years, first tumbled by 285,106bps in 2022, then surged by 332,634bps in 2023.
- Over the past 5 years, Voyager Therapeutics' Operating Margin (Quarterly) stood at 20.31% in 2021, then skyrocketed by 156,440bps to 1,584.71% in 2022, then slumped by 152,468bps to 60.03% in 2023, then crashed by 67,008bps to -610.05% in 2024, then plummeted by 17,236bps to -228.31% in 2025.
- Its last three reported values are -228.31% in Q3 2025, -704.33% for Q2 2025, and -533.74% during Q1 2025.